Smith & Nephew plc (SNN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 24.44 |
| Open | 25.09 |
| Bid | 21.59 x 800 |
| Ask | 24.84 x 800 |
| Day's range | 24.72 - 25.16 |
| 52-week range | 21.53 - 32.71 |
| Volume | |
| Avg. volume | 959,937 |
| Market cap | 10.833B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 41.30 |
| EPS (TTM) | 0.60 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | 0.75 (3.03%) |
| Ex-dividend date | 01 Apr 2024 |
| 1y target est | 30.50 |
The GuardianNearly half of Smith & Nephew investors revolt against CEO pay rise
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Simply Wall St.With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Globe NewswireSmith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
© 2024 Yahoo. All rights reserved.